Seeing the way forward for treatment of CMV retinitis.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000998:Antiviral Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy*; D015828:Eye Infections, Viral / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D017245:Foscarnet; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012173:Retinitis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid; D015774:Ganciclovir